Related Experiment Video
Updated: Nov 10, 2025

Reduced Complications after Arterial Reconnection in a Rat Model of Orthotopic Liver Transplantation
Published on: November 7, 2020
Post-operative heparin reduces early venous thrombotic complications after orthotopic paediatric liver
Giovanna Colombo1, Cinzia Giaccherini2, Alberto Benzi3
1Department of Anaesthesia and Intensive Care, Paediatric Intensive Care Unit, "Papa Giovanni XXIII" Hospital, Bergamo, Italy.
Insights
Early heparin administration after pediatric liver transplants significantly reduces venous thrombosis risk. This safe strategy, without increasing bleeding, offers a promising approach to prevent early graft failure in children.
Area of Science:
- Hepatology
- Transplantation Surgery
- Vascular Surgery
Background:
- Thrombotic complications are a leading cause of graft failure and re-transplantation in pediatric liver transplant recipients.
- Current prevention strategies for thrombosis lack standardization, highlighting a critical unmet need in post-transplant care.
Purpose of the Study:
- To evaluate the efficacy of early postoperative intravenous unfractionated heparin in preventing thrombotic complications following pediatric liver transplantation.
- To compare the incidence of early venous thrombosis (VT) before and after the implementation of a standardized heparin prophylaxis protocol.
Main Methods:
- Retrospective analysis of 479 pediatric liver transplant cases from 2002 to 2016.
- Comparison of VT incidence between patients who received early heparin (10 UI/kg/hr starting 12 hours postoperatively) and those who did not.
- Multivariate analysis to identify risk factors for VT, including heparin use and patient age.
Main Results:
- A significantly lower incidence of venous thrombosis was observed in the heparin group (2.5%) compared to the non-heparin group (7.9%) (p=0.038).
- Heparin prophylaxis was independently associated with a reduced risk of VT (HR=0.29; p=0.045).
- Younger age (<1 year) was identified as an independent risk factor for VT (HR=2.62; p=0.028).
Conclusions:
- Early postoperative heparin administration is a safe and effective strategy for preventing early venous thrombosis after pediatric liver transplantation.
- This approach did not lead to a significant increase in bleeding complications.
- Further randomized controlled trials are warranted to confirm these findings and establish heparin prophylaxis as a standard of care.
Background:
Despite significant improvements in surgical techniques and medical care, thrombotic complications still represent the primary cause of early graft failure and re-transplantation following paediatric liver transplantation. There is still no standardized approach for thrombosis prevention.
Materials And Methods:
The study aimed to evaluate the effectiveness of early intravenous unfractionated heparin started 12 hours postoperatively at 10 UI/kg per hour and used a retrospective "before and after" design to compare the incidence of early thrombotic complications prior to (2002-2010) and after (2011-2016) the introduction of heparin in our institute.
Results:
From 2002 to 2016, 479 paediatric patients received liver transplantation in our institution with an overall survival rate over one year of 0.91 (95% CI: 0.87-0.94). Of 365 eligible patients, 244 did not receive heparin while 121 did receive heparin. We reported a lower incidence of venous thrombosis (VT) in the group treated with heparin: 2.5% (3/121) vs 7.9% (19/244) (p=0.038). All clinical and laboratory variables considered potential risk factors for VT were studied. By multivariate stepwise Cox proportional hazards models, heparin prophylaxis resulted significantly associated to a reduction in VT (HR=0.29 [95% CI: 0.08-0.97], p=0.045), while age <1 year was found to be an independent risk factor for VT (HR=2.62 [95% CI: 1.11-6.21]; p=0.028).
Discussion:
Early postoperative heparin could be considered a valid and safe strategy to prevent early VT after paediatric liver transplantation without a concomitant increase in bleeding. A future randomised control trial is mandatory in order to strengthen this conclusion.
Related Concept Videos
Venous Thrombosis III: Interprofessional Care
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Peripheral Artery Disease V: Postoperative Nursing Management
Kidney Transplant II: Surgical Procedure

